chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Clusters of Hives all over my body. Intense itching/burning. Painful heartburn/acid reflux Still occurring since my booster in November
PATIENT STATES SHE HAS A 2 INCH PINK CIRCLE AROUND THE INJECTION SITE. THIS STARTED ONCE SHE GOT HOME AFTER THE VACCINATION. IT IS NOT SWOLLEN OR SORE, JUST ITCHY. ADVISED PATIENT TO APPLY HYDROCORTISONE, MONITOR, AND CONTACT HER DOCTOR.
Initial symptom of throat tightness and dizziness. At 01:45 pm face became flushed then ears, and right arm. Itching of right arm started at this time also. Treated in ER with Solumedrol, Iv Tagamet and Iv Benadryl at 02:00pm. Discharged home at 5pm, symptoms all gone after treatment.
ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY LEFT FACIAL MUSCLE WEAKNESS
After administering the final vaccine (given in the order of: MENACTRA, Tdap, HPV), patient noted that the HPV one hurt a little bit more. He then noted he was lightheaded and started to lean forward on the chair he had been sitting on, and fell to the ground. PHN then dialed 911 and patient woke up briefly after (total time unconscious approx. 15-20 seconds). PHN gave patient water and had him remain sitting on the floor and took vital signs: BP was 106/80, HR 100. He was observed for 25 minutes and regained his color as he had been pale. Mother declined emergency services. PHN educated on what signs and symptoms to observe for post syncope.
Patient received her first dose of the Pfizer vaccine and appeared well. Patient was told to sit for 30 min to monitor for reaction. After 5 min,  patient reported feeling dizzy, tongue feeling slightly swollen,  chills, slight difficulty swallowing her own saliva. She denied difficulty breathing, racing heart. NP on site notified, who performed a focused assessment and administered 50 mg IV Benadryl IM. Patient was reassessed and monitored by NP and two RN. Patient reported instant symptom relief within 2-4 min, that her chills went away and no issues swallowing and felt "90%" better. After 15 mins patient reported she was feeling symptoms again come back. Patient was escorted to the ED with NP and RN immediately.
Patient received a 3rd dose of Shingles. She requested the vaccine at an off site clinic and did not realize that she already completed the series.
mom descirbed sx following vax recvd 19MAR92, period of unconsolable high pitched crying lasting 1-2 hrs w/no tx;
I receive the 2nd dose around 1230the afternoon of oct 11th and that afternoon  it made it to a small quarter sized red spot at injection site and very sore arm. By the end of the 2nd day the red spot was about half dollar size and lymph nodes in under arm tender. The next day I woke up and the spot was about 2inches wide and about 3.5inches long and my nodes in my underarm were tender.the injection site was swollen And warm .And today 10/14/2021 the red spot is about 4inches wide and about 5inches long still very swollen warm and underarms are extremely sore. I called physician was told to show pharmacist where vacc. Was administered. Was told by pharm to take Benadryl
Metallic salty taste; Metallic salty taste; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (005570). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, MANUFACTURER UNKNOWN), for COVID-19 Immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 Immunization, reaction(s): "No appetite". The following information was reported: DYSGEUSIA (non-serious), DYSGEUSIA (non-serious), outcome "unknown" and all described as "Metallic salty taste".  Additional information: Patient had received two initial and then the booster dose. Patient have been left with a metallic salty taste in mouth after booster dose. Patient had no appetite since the second dose.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Tested positive for Covid 09Jul2022 after booster in May2022; Tested positive for Covid 09Jul2022 after booster in May2022; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and on 01May2022 as dose 3 (booster), single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 09Jul2022, outcome "recovering" and all described as "Tested positive for Covid 09Jul2022 after booster in May2022". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jul2022) Positive. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient received incorrect vaccine. Patient was supposed to receive Hepatitis A, not Menquadfi. Patient is under the recommended age for Menquadfi.
c/o feeling flushed and elevated HR post vaccine administration. Vitals stable BP 155/88, HR 92, No CP, no sob. Recovered and discharged home.
Left arm pain; Heavy head; Fever ( do not know how); Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Left arm pain), HEAD DISCOMFORT (Heavy head), PYREXIA (Fever ( do not know how)) and MYALGIA (Body aches) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Patient had Covid by the end of the past year and the beginning of this year). Concurrent medical conditions included Blood pressure high. Concomitant products included LISINOPRIL for Blood pressure high.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Left arm pain), HEAD DISCOMFORT (Heavy head), PYREXIA (Fever ( do not know how)) and MYALGIA (Body aches). At the time of the report, PAIN IN EXTREMITY (Left arm pain), HEAD DISCOMFORT (Heavy head), PYREXIA (Fever ( do not know how)) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter asked could patient took some Tylenol or ibuprofen.   This case was linked to US-MODERNATX, INC.-MOD-2021-041424 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041424:husband crosslinked case
keeps vomiting, She is unable to keep any food down; She still can't focus on anything; Fever; have not been able to eat; it almost seems like it is getting worse; This is a spontaneous report from a contactable Consumer (Mother). This Female consumer reporting for a 16-year-old daughter (Patient). A 16-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection; Lot Number: EW0173), via an unspecified route of administration as dose 2, single on an unspecified date for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection; Lot Number: Unknown), via an unspecified route of administration as dose 1, single on an unspecified date for covid-19 immunisation and had no side effects. Reporter Stated, Pfizer both for the first one she didn't have any side effect and that was Pfizer BioNTech and this one was like printed in green and it said Pfizer Covid 19 vaccine. Reporter Stated her daughter (patient) had the Pfizer vaccine (Covid 19 Vaccine) yesterday and she had like all the symptoms, and she kept on vomiting, and she was unable to keep any food down and so it's beyond 24 hours what it was been like noon and its now 8 O' clock at night on unspecified date. So, patient still cannot focus on anything, and she just keep on vomiting anything she eats. Reporter just don't understand symptoms like what it was going to alleviate or what should she expect. Reporter Stated no other medical conditions, but she was not able to eat, and it almost seems like it was getting worse she just had fever on unspecified date. Patient just tried taking Tylenol as treatment for side effect. Therapeutic measures were taken as a result of events with Tylenol. At the time of this report, the outcome of events was unknown.  Information about Lot/batch number was available. further information was expected.
Red, hot. Tues evening using ice packs. Worse on Wed swelling. Same on Thurs. Redness worse and puffing on Fri.
Severe body aches, injection arm pain, jaw, neck and tooth pain.  Fever 101. Chills. Headache.  Symptoms began 20 hours post-vaccine. Resolved 20 hours after onset of symptoms, except for residual fatigue.
Patient received dose 1 and 2 of Pfizer/BioNTech vaccine at the first two visits on 12/21/20 and 1/11/21 respectively at her skilled nursing facility. Upon the third visit to the nursing facility on 2/1/21, the patient was erroneously given a 3rd dose of Pfizer/BioNTech COVID-19 vaccine.  This report is being filled out at the time of discovery of the third dose being given, no adverse events have occurred as of this time.
This spontaneous report as received from a physician and health care worker via company representative refers to a 66 year old male patient. Patient medical history and current condition was not reported. On 19-FEB-2015 the patient was vaccinated with PNEUMOVAX 23, 0.5 ml and patient experienced injection site adverse reactions right after receiving the PNEUMOVAX 23 on the same day. Patient developed redness and swelling around the injection site. Also reported that the site was painful, large and the injection site was very hard. The patient was provided treatment with ice on the injection site. The outcome of the events was reported as recovered (date unspecified). Causality assessment was not provided by the reporter. This case is one of the two reports from the same reporter. Additional information has been requested.
Pt, 18 yo male, right out of high school, in excellent heath, is a firefighter recruit.  10/04/21 - Felt like his chest was burning.  Said he had heartburn. 10/08/21 - While in the middle of EMT class, he almost passed out.  Senior firefighters drove him directly to local Medical center for treatment after they checked his heart rate and blood pressure.  He was diagnosed with MYOCARDITIS, given a series of oral steroids and an inhaler.  He  was also tested for Covid19 (PCR) on 10/08/21 and his results came back NEGATIVE on 10/10/21.
12 hours after injection, arm became extremely painful, pt unable to move arm  due to pain. Achy from head to toe. Fever. These symptoms began to improve on 8/6/09- 3 days after the injection. He missed at least 2 days of work.
Sore left arm from elbow to shoulder lasted 24 hours. Could not lift my left arm straight up above my head.  Difficult time carryiing any weight in my left arm.
7 data after the vaccine was give, the injection site became very itchy. On the 8th day the area became inflamed, warm to touch, red, painful, and felt firm to touch. This has continued since day 8.
Severe pain in arm, limited movement of arm, nausea, chills, headache.
Immediately following the first dose of the Pfizer vaccine, I developed hives on my left arm (the same arm I had the vaccine), arm soreness, stiff neck, fatigue, nausea and dizziness. This lasted for about 5 days. 6 days after receiving the vaccine, I developed severe chills and rashes on my joints (knees, toes, knuckles, fingers) in addition to the other symptoms. I was admitted to the ED and tests done were all normal. The ED physicians concluded that I was having an atypical reaction to the vaccine. For 3 months following the vaccine, I had the symptoms previously mentioned in addition to weakness in my arms and legs, brain fog/difficulty forming sentences, extreme fatigue, swollen lymph nodes, tremors, migraines, blurry vision, balance issues and dizziness. I had not experienced any of these symptoms prior to administration of the vaccine. After the vaccine I also suddenly developed hypothyroidism and my labs showed that I was anemic on 3/19/21, and this is still the case today (7 months later). I was admitted to the ED at least 5 times during this period of 3 months due to the symptoms listed.
Patient was seen on 3/6/23 for the second dose of MenB and when asked if she had any reactions to the previous dose, she and her parent started describing arm pain that she has had since the initial administration. They report it hurts as soon as the dose was administered, constantly for about a week after the administration, and has caused her discomfort almost daily since the constant pain subsided. The pain she rates anywhere from a 5 to 8 out of 10 when it is bothering her. There was no knot appreciated on physical exam by RN, but patient did report discomfort with light squeezing and pressure while doing the assessment. Dose was not given.
neuropathy symptoms; Burning in bilateral ischial tuberosities and hip pain; Lumbar discomfort/ Hip pain; have an MRI which should some stenosis L4/L5/S1 level; Left shoulder tendonitis sever to point of non-use/Right Shoulder tendonitis used arm but difficult; The initial case was missing the following minimum criteria hence considered as invalid as Unspecified product and Unspecified AE. Upon receipt of follow-up information on (01Aug2022), this case now contains all required information to be considered valid.  This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP), Program ID: (003110). The reporter is the patient.  A 72-year-old female patient received BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: EL9267) and on 03Mar2021 as dose 2, single (Lot number: EN6204) at the age of 70 years for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: TENDONITIS (non-serious) with onset Apr2021, outcome "not recovered", described as "Left shoulder tendonitis sever to point of non-use/Right Shoulder tendonitis used arm but difficult"; NEUROPATHY PERIPHERAL (hospitalization, medically significant), outcome "unknown", described as "neuropathy symptoms"; BURNING SENSATION (hospitalization), outcome "not recovered", described as "Burning in bilateral ischial tuberosities and hip pain"; ARTHRALGIA (hospitalization), outcome "not recovered", described as "Lumbar discomfort/ Hip pain"; LUMBAR SPINAL STENOSIS (hospitalization), outcome "unknown", described as "have an MRI which should some stenosis L4/L5/S1 level". The patient underwent the following laboratory tests and procedures: Magnetic resonance imaging: showed some stenosis. Therapeutic measures were taken as a result of burning sensation, tendonitis.  Clinical course: The patient received the suspect vaccination on left and right deltoid. She received P.T (physical therapy) for burning and hips in Aug2021. Provided W/stretch her bilateral tendonitis and burning and lumber discomfort. The patient never root injections had no improvement either time. The patient did had a MRI which should some stenosis L4/L5/S1 level, where she saw neurologist, took advised she was not currently a candidate for surgery. So she tried nerve root block injections for and only temporary (24hrs) relief. Hip pain continued as well as burning sensation-attributed to stenosis but not experienced prior to vaccine injections. Her belief was that vaccinations contributed to tendonitis and neuropathy sysmptoms. At least stirred things up to the point where she noticed changes in how she walk and move in general - hip pain was intermittent but burning sensation was 24/7 for past 16 months. The patient had no AE following prior vaccinations.
No adverse effects were reported in the patient.; a patient received a vaccine following a temperature excursion; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medications, pertinent medical history, drug reactions or allergies was not provided.      On 25-OCT-2019, the patient was vaccinated with improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (dosage detail, strength, lot # and expiration date were not reported) orally for prophylaxis.  Administered doses of vaccine experienced temperature excursion of below 36 Fahrenheit degrees (2 Celsius degree) (also reported as 35 Fahrenheit degrees) for 430 minutes. There was no previous temperature excursion. Digital data logger was not involved. No adverse effects were reported.
Patient got hyperhidrosis of the hands and feet after the vaccine and also depression, neither of which she had had before. We asked for just the tetanus vaccine, but was administered DTaP.
Left arm was red from shoulder to elbow.  Left arm was also swollen and slight tenderness.  Edema and erythema were remarkable.
Big red patch at injection site hard red itchy I also cant smell or taste n have trouble breathing out of my nostrils they?re clogged or stuffy
Arm vaccine administered in developed redness, soreness, swelling the next day. Seen on day 2 , given ice. On day 4 redness had spread seen in ED and admitted to hospital with cellulitis.
I had sore throat, stuff head, cough, and weird tasted in mouth. These symptoms lasted about 2 weeks.  I got a COVID-19 test, positive result.
Still has arm pain and decreased range of motion 4 1/2 months after SHINGRIX administered. Had pain immediately after receiving vaccine.
pt recv vax 12FEB97 in AM & mom gave APAP q 4hr last dose 8-9PM;pt moaning 1AM, t105.3;w/in 1hr had vomited once in pM 12FEB97;poor appetite;
- Started with fever/rash 4-4-12. - Saw MD 4-5-12 rash had moved from face to trunk. 4-6 mm macular rash with flesh colored papules. MD diagnosed as Rubella.
t104, sz, pt hospitalized adm on 19MAY-21MAY92;
This non-serious medically confirmed report (initial receipt 17-SEP-2014) concerns an approximately 50 year old female patient who was generally healthy with no co-morbidities. The patient had received flu vaccines in the past. On the 17-SEP-2014, the patient received the AFLURIA  vaccine (batch number not reported) 0.5 ml via the intramuscular route. The pharmacist who was administering the vaccine on the 17-SEP-2014 stated that she was unable to depress the plunger from the pre-filled syringe. The syringe plunger stopped moved and the pharmacist (who had administered vaccines before) was afraid to use the additional force. The pharmacist removed the syringe and could still see visible liquid in the syringe. The patient did not receive the full amount of intended vaccine. The patient appeared fine and remained in the pharmacy at least another 10 minutes with no problems, in which the patient's appeared fine and remained in the pharmacy at least another 10 minutes with no problems, in which the patient's husband received the AFLURIA injection from the same box without any issues. The patient was not re-vaccinated. Outcome was recovered.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 19-AUG-2014 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 (strength: 0.5ml, lot # K005957, expiration date 08-MAR-2015, route unspecified). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time was 1656 hours with lowest recorded temperature of 20 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
hyporesponsive x 36 hrs; pale initially; more irritable x 6 wk; little spontaneous movements 1st 36hrs;
Blood pressure dropped really low 77/58; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported history.).    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58). On 18-Jan-2021, BLOOD PRESSURE DECREASED (Blood pressure dropped really low 77/58) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information provided. No treatment information provided.
My son had a mild fever of 100F on the afternoon the day after the second dose of the Pfizer COVID 19 vaccine, while we were in line for lunch he said he had a stomach ache, and he moved closer to me. I asked if he was going to vomit, at that point his eyes went blank and he fainted to the floor. He was unconscious for about a minute, I carried him over to a chair, and he remained slumped over for a few minutes while I thought maybe his blood sugar was low (this has never happened before). I got him a Coke to drink and he gradually improved, but complained of a sore stomach as well as sore arm at the site of the injection. He felt "woozie" the next day at school but did not pass out.
Vaccine remained in the freezer past the recommended guidelines (14 days). Once discovered, Pfizer was contacted but did not have stability data to support acceptability of the product greater than 31 days in the freezer. All patients that were administered vaccine past 31 days were contacted and given an option to be re-vaccinated based on their doctor'S recommendation or ACIP guidance.
doses administered past the 30-day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    In February 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses administered past the 30-day use by date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Date the vial was initially stored in the refrigerator on 14Jan2022. Reporter stated that vial does not undergo any temperature excursions. No treatment medications were reported.
I had my vaccination on 10/10/2022. I started to have symptoms to include lethargy fever chills congestions sneezing on 12/03/2022. I tested COVID-19 positive on 12/04/2022. I was prescribed LAGEVRIO. I presently feel better on 01/10/2022.
Information has been received from a physician concerning a 6 year old male who was vaccinated SC with a 0.5ml dose of Varivax. On 27-MAR-2006 the patient experienced breakthrough varicella. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.